Fewer CTL, not enhanced NK cells, are sufficient for viral clearance from the lungs of immunocompromised mice

Cellular Immunology

Volumn 226, Issue 1, 2003, Pages 54-64

  Neff LaFord, Haley D ^a   Vorderstrasse, Beth A ^a   Lawrence, B Paige ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Ah receptor; Anti viral immunity; CTL; Cytokines; Dioxin (TCDD); IFN ; Immune suppression; In vivo; Influenza virus; NK cells

Indexed keywords

ALPHA INTERFERON; AROMATIC HYDROCARBON RECEPTOR; BETA INTERFERON; CD8 ANTIGEN; CYTOKINE; DIOXIN; INTERLEUKIN 1; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DEPLETION; DRUG EXPOSURE; DRUG POTENCY; FEMALE; IMMUNE DEFICIENCY; INFLUENZA; INFLUENZA VIRUS; LYMPHOCYTE COUNT; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION;

INFLUENZA VIRUS;

EID: 1642554776     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2003.11.005     Document Type: Article

References (61)

1. Anderson R.N. Deaths: leading causes for 2000. Natl. Vital Stats. Reports. 150:2002;1-86.
2. Postema A., Brammer L., Hall H., Klimov A., Uyeki T., Fukuda K., Cox N., Terebuh P. Update: influenza activity - United States, 2002-03 season. Morb. Mortal. Wkly. Rep. 52:2003;26-28.
3. Crowe J.E. Jr. Host responses to respiratory virus infection and immunization. Curr. Top. Microbiol. Immunol. 236:1999;191-214.
4. Doherty P.C., Topham D.J., Tripp R.A., Cardin R.D., Brooks J.W., Stevenson P.G. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159:1997;105-117.
5. Karzon D. Cytotoxic T cells in influenza immunity. Semin. Virol. 7:1996;265-271.
6. Eichelberger M., Allan W., Zijlstra M., Jaenisch R., Doherty P.C. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J. Exp. Med. 174:1991;875-880.
7. + T cells. J. Immunol. 144:1990;3980-3986.
8. Doherty P.C., Allan W., Eichelberger M., Carding S.R. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu. Rev. Immunol. 10:1992;123-151.
9. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:1999;189-220.
10. Stein-Streilein J., Guffee J. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 136:1986;1435-1441.
11. Kos F.J., Engleman E.G. Requirement for natural killer cells in the induction of cytotoxic T cells. J. Immunol. 155:1995;578-584.
12. Kos F.J., Engleman E.G. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell. Immunol. 173:1996;1-6.
13. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet. Microbiol. 74:2000;109-116.
14. Heise M.T., Pollock J.L., O'Guin A., Barkon M.L., Bormley S., Virgin H.W.T. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon. Virology. 241:1998;331-344.
15. ′ -oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells J. Immunol. 158:1997;2363-2374.
16. Cousens L.P., Orange J.S., Su H.C., Biron C.A. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA. 94:1997;634-639.
17. Hunter C.A., Gabriel K.E., Radzanowski T., Neyer L.E., Remington J.S. Type I interferons enhance production of IFN-gamma by NK cells. Immunol. Lett. 59:1997;1-5.
18. Lehmann C., Sprenger H., Nain M., Bacher M., Gemsa D. Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression. Res. Virol. 147:1996;123-130.
19. Okamura H., Kashiwamura S., Tsutsui H., Yoshimoto T., Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. 10:1998;259-264.
20. Pirhonen J., Sareneva T., Kurimoto M., Julkunen I., Matikainen S. Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J. Immunol. 162:1999;7322-7329.
21. Neuzil K.M., Graham B.S. Cytokine release and innate immunity in respiratory viral infection. Semin. Virol. 7:1996;255-264.
22. Lawrence B.P., Warren T.K., Luong H. Fewer T lymphocytes and decreased pulmonary influenza virus burden in mice exposed to 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD). J. Toxicol. Environ. Health A. 61:2000;39-53.
23. Mitchell K.A., Lawrence B.P. Exposure to 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD) renders influenza virus-specific CD8+ T cells hyporesponsive to antigen. Toxicol. Sci. 74:2003;74-84.
24. Vorderstrasse B.A., Bohn A.A., Lawrence B.P. Examining the relationship between impaired host resistance and altered immune function in mice treated with TCDD. Toxicology. 188:2003;15-28.
25. Warren T.K., Mitchell K.A., Lawrence B.P. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol. Sci. 56:2000;114-123.
26. Burleson G.R., Lebrec H., Yang Y.G., Ibanes J.D., Pennington K.N., Birnbaum L.S. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fundam. Appl. Toxicol. 29:1996;40-47.
27. House R.V., Lauer L.D., Murray M.J., Thomas P.T., Ehrlich J.P., Burleson G.R., Dean J.H. Examination of immune parameters and host resistance mechanisms in B6C3F1 mice following adult exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Toxicol. Environ. Health. 31:1990;203-215.
28. Luebke R.W., Copeland C.B., Bishop L.R., Daniels M.J., Gilmour M.I. Mortality in dioxin-exposed mice infected with influenza: mitochondrial toxicity (Reye's-like syndrome) versus enhanced inflammation as the mode of action. Toxicol. Sci. 69:2002;109-116.
29. Nohara K., Izumi H., Tamura S., Nagata R., Tohyama C. Effect of low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza A virus-induced mortality in mice. Toxicology. 170:2002;131-138.
30. Behnisch P.A., Hosoe K., Sakai S. Combinatorial bio/chemical analysis of dioxin and dioxin-like compounds in waste recycling, feed/food, humans/wildlife and the environment. Environ. Int. 27:2001;495-519.
31. Denison M.S., Pandini A., Nagy S.R., Baldwin E.P., Bonati L. Ligand binding and activation of the Ah receptor. Chem. Biol. Interact. 141:2002;3-24.
32. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43:2003;309-334.
33. Kerkvliet N.I. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int. Immunopharmacol. 2:2002;277-291.
34. Birnbaum L.S. Distribution and excretion of 2,3,7,8-tetrachlorodibenzo-p- dioxin in congenic strains of mice which differ at the Ah locus. Drug Metab. Dispos. 14:1986;34-40.
35. Zhang W.J., Sarawar S., Nguyen P., Daly K., Rehg J.E., Doherty P.C., Woodland D.L., Blackman M.A. Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice. J. Immunol. 157:1996;5049-5060.
36. Monteiro J.M., Harvey C., Trinchieri G. Role of interleukin-12 in primary influenza virus infection. J. Virol. 72:1998;4825-4831.
37. Barrett T., Inglis S.C. Growth, purification and titration of influenza viruses. Mahy B.W.J. Virology: A Practical Approach. 1985;119-150 IRL Press, Oxford.
38. Flick D.A., Gifford G.E. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods. 68:1984;167-175.
39. Gearing A.J., Bird C.R., Bristow A., Poole S., Thorpe R. A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3). U/ml of interleukin-2 J. Immunol. Methods. 99:1987;7-11.
40. Orange J.S., Biron C.A. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:1996;4746-4756.
41. Nonacs R., Humborg C., Tam J.P., Steinman R.M. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J. Exp. Med. 176:1992;519-529.
42. Flynn K.J., Riberdy J.M., Christensen J.P., Altman J.D., Doherty P.C. In vivo proliferation of naive and memory influenza-specific CD8(+) T cells. Proc. Natl. Acad. Sci. USA. 96:1999;8597-8602.
43. Turner S.J., Cross R., Xie W., Doherty P.C. Concurrent naive and memory CD8(+) T cell responses to an influenza A virus. J. Immunol. 167:2001;2753-2758.
44. Clark G.C., Taylor M.J. Tumor necrosis factor involvement in the toxicity of TCDD: the role of endotoxin in the response. Exp. Clin. Immunogenet. 11:1994;136-141.
45. Fan F., Yan B., Wood G., Viluksela M., Rozman K.K. Cytokines (IL-1beta and TNFalpha) in relation to biochemical and immunological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology. 116:1997;9-16.
46. Funseth E., Wesslen L., Lindh U., Friman G., Ilback N.G. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on trace elements, inflammation and viral clearance in the myocardium during coxsackievirus B3 infection in mice. Sci. Total Environ. 284:2002;135-147.
47. Moos A.B., Baecher-Steppan L., Kerkvliet N.I. Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8- tetrachlorodibenzo-p-dioxin: the role of proinflammatory cytokines, IL-1 and TNF. Toxicol. Appl. Pharmacol. 127:1994;331-335.
48. Yin H., Li Y., Sutter T.R. Dioxin-enhanced expression of interleukin-1β in human epidermal keratinocytes: potential role in the modulation of immune and inflammatory responses. Exp. Clin. Immunogenet. 11:1994;128-135.
49. Tone M., Thompson S.A., Tone Y., Fairchild P.J., Waldmann H. Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J. Immunol. 159:1997;6156-6163.
50. Kurosawa S., Harada M., Matsuzaki G., Shinomiya Y., Terao H., Kobayashi N., Nomoto K. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. Immunology. 85:1995;338-346.
51. + natural killer cells producing interferon-gamma in xenospecific cytotoxic T lymphocyte differentiation. Transplantation. 68:1999;840-843.
52. Suzuki R., Suzuki S., Ebina N., Kumagai K. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2. J. Immunol. 134:1985;2139-2148.
53. Ernst M., Flesch-Janys D., Morgenstern I., Manz A. Immune cell functions in industrial workers after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: dissociation of antigen-specific T-cell responses in cultures of diluted whole blood and of isolated peripheral blood mononuclear cells. Environ. Health Perspect. 106:1998;701-705.
54. Zeytun A., McKallip R.J., Fisher M., Camacho I., Nagarkatti M., Nagarkatti P.S. Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays. Toxicology. 178:2002;241-260.
55. Jeon M.S., Esser C. The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J. Immunol. 165:2000;6975-6983.
56. Kerkvliet N.I., Baecher-Steppan L., Shepherd D.M., Oughton J.A., Vorderstrasse B.A., DeKrey G.K. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Immunol. 157:1996;2310-2319.
57. Nohara K., Fujimaki H., Tsukumo S., Inouye K., Sone H., Tohyama C. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57Bl/6 mice. Toxicology. 172:2002;49-58.
58. Prell R.A., Oughton J.A., Kerkvliet N.I. Effect of 2,3,7,8- tetrachlorodibenzo-p-dioxin on anti-CD3-induced changes in T-cell subsets and cytokine production. Int. J. Immunopharmacol. 17:1995;951-961.
59. Mantovani A., Vecchi A., Luini W., Sironi M., Candiani G.P., Spreafico F., Garattini S. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on macrophage and natural killer cell-mediated cytotoxicity in mice. Biomedicine. 32:1980;200-204.
60. + T cells in an in vivo response. J. Immunol. 155:1995;3719-3721.
61. Choi J.Y., Oughton J.A., Kerkvliet N.I. Functional alterations in CD11b(+)Gr-1(+) cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Int. Immunopharmacol. 3:2003;553-570.